184 related articles for article (PubMed ID: 16699266)
1. Tachykinin receptors as drug targets for motility disorders.
Hoogerwerf WA; Sarna SK
Dig Dis; 2006; 24(1-2):83-90. PubMed ID: 16699266
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].
Jovanović-Mićić D; Janković S; Beleslin DB
Srp Arh Celok Lek; 1994; 122(1-2):50-4. PubMed ID: 17972806
[TBL] [Abstract][Full Text] [Related]
3. [Gastrointestinal motility disorders and drugs: opioids, calcium antagonists, nitrates, peptides, prostaglandins and 5-hydroxytryptaminergic drugs (part II)].
Jovanović-Mićić D; Samardzić R; Beleslin B
Srp Arh Celok Lek; 1994; 122(3-4):88-92. PubMed ID: 17972818
[TBL] [Abstract][Full Text] [Related]
4. Tachykinin receptors in the gut: physiological and pathological implications.
Holzer P; Holzer-Petsche U
Curr Opin Pharmacol; 2001 Dec; 1(6):583-90. PubMed ID: 11757813
[TBL] [Abstract][Full Text] [Related]
5. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
Manabe N; Wong BS; Camilleri M
Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
[TBL] [Abstract][Full Text] [Related]
6. [Medicamentous modification of gastrointestinal motility and secretion].
Allescher HD
Z Gastroenterol; 1991 Apr; 29 Suppl 3():27-30. PubMed ID: 1648290
[TBL] [Abstract][Full Text] [Related]
7. Ion channels as targets for treatment of gastrointestinal motility disorders.
Farrugia G
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():135. PubMed ID: 18924455
[No Abstract] [Full Text] [Related]
8. CCK1 antagonists: are they ready for clinical use?
Peter SA; D'Amato M; Beglinger C
Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265
[TBL] [Abstract][Full Text] [Related]
9. New pharmacologic therapies in gastrointestinal disease.
Wallace JL; Ferraz JG
Gastroenterol Clin North Am; 2010 Sep; 39(3):709-20. PubMed ID: 20951926
[TBL] [Abstract][Full Text] [Related]
10. Motility disorders in the ICU: recent therapeutic options and clinical practice.
Röhm KD; Boldt J; Piper SN
Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387
[TBL] [Abstract][Full Text] [Related]
11. Potential of ghrelin as a therapeutic approach for gastrointestinal motility disorders.
Peeters TL
Curr Opin Pharmacol; 2006 Dec; 6(6):553-8. PubMed ID: 17011824
[TBL] [Abstract][Full Text] [Related]
12. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases.
Sanger GJ
Drug Discov Today; 2008 Mar; 13(5-6):234-9. PubMed ID: 18342799
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
Camilleri M
Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
[No Abstract] [Full Text] [Related]
14. Drugs targeting functional bowel disorders: insights from animal studies.
Sanger GJ; Hicks GA
Curr Opin Pharmacol; 2002 Dec; 2(6):678-83. PubMed ID: 12482730
[TBL] [Abstract][Full Text] [Related]
15. [On the possibility of using prokinetics in gastroenterology].
Sheptulin AA; Vize-Khripunova MA
Klin Med (Mosk); 2010; 88(5):19-22. PubMed ID: 21089451
[TBL] [Abstract][Full Text] [Related]
16. Selective and combined neurokinin receptor antagonists.
Gerspacher M
Prog Med Chem; 2005; 43():49-103. PubMed ID: 15850823
[No Abstract] [Full Text] [Related]
17. Potential pharmacological approaches to management of gut motility disorders.
Malagelada JR
Scand J Gastroenterol Suppl; 1984; 96():111-26. PubMed ID: 6382573
[TBL] [Abstract][Full Text] [Related]
18. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases.
Lecci A; Maggi CA
Expert Opin Ther Targets; 2003 Jun; 7(3):343-62. PubMed ID: 12783571
[TBL] [Abstract][Full Text] [Related]
19. 5-HT4 receptor agonists: similar but not the same.
De Maeyer JH; Lefebvre RA; Schuurkes JA
Neurogastroenterol Motil; 2008 Feb; 20(2):99-112. PubMed ID: 18199093
[TBL] [Abstract][Full Text] [Related]
20. [Prokinetic drugs in gastroenterology].
Galmiche JP; Bruley des Varannes S; Le Bodic L
Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
